These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38349208)

  • 1. Nonoperative, Active Surveillance of Larger Malignant and Suspicious Thyroid Nodules.
    Altshuler B; Bikas A; Pappa T; Marqusee E; Cho NL; Nehs MA; Liu JB; Doherty GM; Landa I; Ahmadi S; Alexander EK
    J Clin Endocrinol Metab; 2024 Jul; 109(8):1996-2002. PubMed ID: 38349208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experience with Active Surveillance of Thyroid Low-Risk Carcinoma in a Developing Country.
    Sanabria A
    Thyroid; 2020 Jul; 30(7):985-991. PubMed ID: 31950887
    [No Abstract]   [Full Text] [Related]  

  • 3. Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations.
    Hodax JK; Bowerman K; Quintos JB
    J Pediatr Endocrinol Metab; 2019 Aug; 32(8):895-901. PubMed ID: 31271555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer.
    Schumm MA; Shu ML; Hughes EG; Nikiforov YE; Nikiforova MN; Wald AI; Lechner MG; Tseng CH; Sajed DP; Wu JX; Yeh MW; Livhits MJ
    JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):735-742. PubMed ID: 37382944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy?
    Ajmal S; Rapoport S; Ramirez Batlle H; Mazzaglia PJ
    J Am Coll Surg; 2015 Jun; 220(6):987-92. PubMed ID: 25667137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constructing a nomogram based on the distribution of thyroid nodules and suspicious lateral cervical lymph nodes in fine-needle aspiration biopsies to predict metastasis in papillary thyroid carcinoma.
    Liu SQ; Feng JW; Yan ZT; Xing XX; Jiang WY; Jiang Y; Qian F; Xing W
    Front Endocrinol (Lausanne); 2023; 14():1242061. PubMed ID: 38089614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the Afirma Xpression Atlas for cytologically indeterminate, Afirma Genomic Sequencing Classifier suspicious thyroid nodules: Clinicopathologic analysis with postoperative molecular testing.
    Munoz-Zuluaga CA; Heymann JJ; Solomon JP; Patel A; Siddiqui MT; Scognamiglio T; Gokozan HN
    Am J Clin Pathol; 2024 May; 161(5):463-468. PubMed ID: 38104250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Undercover active surveillance of small highly suspicious thyroid nodules without fine needle aspiration.
    Kim CA; Yoo J; Oh HS; Jeon MJ; Chung SR; Baek JH; Kim WB; Shong YK; Kim WG
    Endocrine; 2024 May; 84(2):615-624. PubMed ID: 37995012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The diagnostic accuracy of ultrasound-guided fine-needle aspiration biopsy and the sonographic differences between benign and malignant thyroid nodules 3 cm or larger.
    Yoon JH; Kwak JY; Moon HJ; Kim MJ; Kim EK
    Thyroid; 2011 Sep; 21(9):993-1000. PubMed ID: 21834673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active Surveillance for Papillary Thyroid Microcarcinoma in a Population with Restrictive Diagnostic Workup Strategies.
    Lončar I; van Dijk SPJ; Metman MJH; Lin JF; Kruijff S; Peeters RP; Engelsman AF; van Ginhoven TM
    Thyroid; 2021 Aug; 31(8):1219-1225. PubMed ID: 33430696
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence and associated malignancy of Bethesda category III cytologies of thyroid nodules assigned to the "cytological atypia" or "architectural atypia" groups.
    García Pascual L; Surralles ML; Morlius X; Garcia Cano L; González Mínguez C
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Dec; 65(10):577-583. PubMed ID: 30262240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy.
    Walters BK; Garrett SL; Aden JK; Williams GM; Butler-Garcia SL; Newberry TR; Mckinlay AJ
    Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1064-1068. PubMed ID: 33567896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).
    Ho AS; Sarti EE; Jain KS; Wang H; Nixon IJ; Shaha AR; Shah JP; Kraus DH; Ghossein R; Fish SA; Wong RJ; Lin O; Morris LG
    Thyroid; 2014 May; 24(5):832-9. PubMed ID: 24341462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bethesda System Categories of Fine Needle Aspiration Cytology Are Not Associated with Thyroid Nodule Location: A Single Institution Experience.
    Xavier-Júnior JCC; Abrantkoski Borges F; Pizzello Zogheib RJ; Camilo-Júnior DJ
    Acta Cytol; 2021; 65(1):22-26. PubMed ID: 32877898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digital image-assisted quantitative nuclear analysis improves diagnostic accuracy of thyroid fine-needle aspiration cytology.
    Chain K; Legesse T; Heath JE; Staats PN
    Cancer Cytopathol; 2019 Aug; 127(8):501-513. PubMed ID: 31150162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the modification of the diagnostic criteria in the 2017 Bethesda System for Reporting Thyroid Cytopathology: a report of a single institution in Japan.
    Higuchi M; Hirokawa M; Kanematsu R; Tanaka A; Suzuki A; Yamao N; Hayashi T; Kuma S; Miyauchi A
    Endocr J; 2018 Dec; 65(12):1193-1198. PubMed ID: 30282887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of malignancy in patients with cytologically suspicious thyroid nodules.
    Castro MR; Espiritu RP; Bahn RS; Henry MR; Gharib H; Caraballo PJ; Morris JC
    Thyroid; 2011 Nov; 21(11):1191-8. PubMed ID: 22007937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma.
    Evranos B; Polat SB; Baser H; Ozdemir D; Kilicarslan A; Yalcin A; Ersoy R; Cakir B
    Cytopathology; 2017 Aug; 28(4):259-267. PubMed ID: 27666595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined role of ultrasound and frozen section in surgical management of thyroid nodules read as suspicious for papillary thyroid carcinoma on fine needle aspiration biopsy: a retrospective study.
    Moon HJ; Kwak JY; Kim EK; Kim MJ; Park CS; Chung WY; Son EJ
    World J Surg; 2009 May; 33(5):950-7. PubMed ID: 19288281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Tumor Size With Histologic and Clinical Outcomes Among Patients With Cytologically Indeterminate Thyroid Nodules.
    Valderrabano P; Khazai L; Thompson ZJ; Otto KJ; Hallanger-Johnson JE; Chung CH; Centeno BA; McIver B
    JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):788-795. PubMed ID: 30027226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.